The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInterserve Regulatory News (IRV)

  • There is currently no data for IRV

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Section 430 (2B) Companies Act Statement

2 Oct 2017 07:00

RNS Number : 3323S
Interserve PLC
02 October 2017
 

Release

2 October 2017

 

SECTION 430 (2B) COMPANIES ACT STATEMENT - TIM HAYWOOD

 

Following the announcement on 30 June 2017, Tim Haywood stepped down as Group Finance Director and as a director of Interserve Plc at the close of business on 30 September 2017.

 

The following arrangements, which comply with Interserve's remuneration policy approved by shareholders in 2015, will apply to Tim's remuneration.

 

Payments and benefits

Tim is to remain with the Company until 30 November 2017 both to support Debbie White and assist in the transition to his successor, Mark Whiteling, who joined the Board yesterday. In line with his contractual provisions, he will continue to receive his salary, pension, a fully expensed company car and other contractual benefits for that period. In addition Tim will receive a payment of £1,935 in respect of his accrued but untaken holiday entitlement as at 30 September. Tim will then receive monthly payments of £31,518.75 (equivalent to his basic monthly salary) in lieu of the twelve months' notice period included in his contract for the period through to 30 November 2018, unless he obtains a comparable position whereby he is directly or indirectly remunerated (whether by way of salary, bonus, pension, fees, equity or otherwise) in which case the monthly payments from Interserve will be reduced or extinguished by the amount of that direct or indirect remuneration. In addition to this, a contribution of £7,500 has been made towards legal fees incurred by Tim in connection with his departure.

 

Annual Bonus payment

Tim is a participant in the Annual Variable Pay Scheme for the financial year ending 31 December 2017. The amount of any payment will be subject to the satisfaction of the relevant performance conditions, as set-out on page 63 of the Directors' Remuneration Report, and a pro-rata reduction up to 30 November 2017 and will be determined by the Remuneration Committee in March 2018.

Share awards

Awards granted under the 2015 Performance Share Plan will, after application of the performance conditions, will be reduced pro rata to 30 November 2017. The two-year holding period, clawback and recovery and withholding provisions contained within the relevant awards will apply to any vested shares. Any dividend equivalents will be satisfied in cash following the vesting date in accordance with the rules of the Plan

 

Tim's awards under the all-employee Sharesave Plan and Share Incentive Plan will be treated in accordance with the rules of the respective plans.

 

The relevant remuneration information relating to Tim Haywood will be included in the Directors' Remuneration Report in the Annual Accounts for the year ending 31 December 2017.

 

In accordance with section 430(2B) of the Companies Act 2006, the information contained in this document will be made available on the Company's website until the Company's next Directors' Remuneration Report is made available.

 

Ends

 

For further information please contact:

 

Rhys Jones, Group Head of PR +44 (0) 7909 605336

 

Richard Campbell/Michael Kinirons +44 (0) 203 219 8816

CNC Communications

 

About Interserve

 

Interserve is one of the world's foremost support services and construction companies. Our vision is to redefine the future for people and places. Everything we do is shaped by our core values. We are a successful, growing, international business: a leader in innovative and sustainable outcomes for our clients and a great place to work for our people. We offer advice, design, construction, equipment, facilities management and frontline public services. We are headquartered in the UK and listed in the FTSE. We have gross revenues of £3.7 billion and a workforce of circa 80,000 people worldwide.

www.interserve.com

 

For news follow @interservenews

 

Legal identifier number: 549300MVYY4EZCRFHZ09

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFFLIDLLIID
Date   Source Headline
15th Mar 20196:27 pmRNSInterserve
15th Mar 20195:56 pmRNSSuccessful completion of sale of the Group
15th Mar 20192:47 pmRNSHolding(s) in Company
15th Mar 20192:01 pmRNSParent Company Administration
15th Mar 201912:33 pmRNSResult of General Meeting
14th Mar 201911:41 amRNSTotal Voting Rights and Warrant Update
14th Mar 20199:18 amRNSDirector/PDMR Shareholding
12th Mar 20198:30 amRNSBlock Listing Application
11th Mar 20195:27 pmRNSResponse to media reports re Deleveraging Plan
5th Mar 201912:56 pmRNSResponse to proposal Coltrane Asset Management L.P
4th Mar 20196:03 pmRNSUpdate on Coltrane Asset Management L.P Proposal
28th Feb 20199:58 amRNSPublication of a Prospectus
27th Feb 20199:05 amRNSDeleveraging Plan details and launch
27th Feb 20198:58 amRNSFull Year Results 2018
26th Feb 20194:17 pmRNSNotice of Requisition General Meeting
22nd Feb 20193:54 pmRNSHolding(s) in Company
22nd Feb 20193:50 pmRNSUpdate on Deleveraging Plan
20th Feb 20199:56 amRNSHolding(s) in Company
19th Feb 201910:13 amRNSHolding(s) in Company
13th Feb 20194:25 pmRNSDirector/PDMR Shareholding
12th Feb 20197:00 amRNSDirectorate Change
6th Feb 20197:10 amRNSStatement re Shareholder Requisition
6th Feb 20197:00 amRNSStatement re Deleveraging Plan
24th Jan 201912:07 pmRNSSecond Price Monitoring Extn
24th Jan 201912:02 pmRNSPrice Monitoring Extension
16th Jan 20191:14 pmRNSDirector/PDMR Shareholding
14th Jan 20194:41 pmRNSSecond Price Monitoring Extn
14th Jan 20194:36 pmRNSPrice Monitoring Extension
2nd Jan 201912:30 pmRNSHolding(s) in Company
2nd Jan 20197:00 amRNSBlock listing Interim Review
28th Dec 20184:20 pmRNSHolding(s) in Company
21st Dec 20187:00 amRNSProgress on Deleveraging Plan
17th Dec 20182:52 pmRNSDirector/PDMR Shareholding
10th Dec 20189:30 amRNSInterserve Awarded £25m Contract.
10th Dec 20187:00 amRNSDELEVERAGING PLAN
29th Nov 20182:30 pmRNSHolding(s) in Company
28th Nov 201810:50 amRNSHolding(s) in Company
27th Nov 20183:59 pmRNSHolding(s) in Company
23rd Nov 20182:07 pmRNSHolding(s) in Company
23rd Nov 20187:00 amRNS3rd Quarter Update
16th Nov 20184:12 pmRNSHolding(s) in Company
16th Nov 20184:09 pmRNSHolding(s) in Company
13th Nov 20182:50 pmRNSStatement following recent press coverage
13th Nov 201811:00 amRNSDirector/PDMR Shareholding
23rd Oct 201811:03 amRNSHolding(s) in Company
22nd Oct 20184:27 pmRNSHolding(s) in Company
17th Oct 20189:04 amRNSDirector/PDMR Shareholding
2nd Oct 20187:00 amRNSSALE OF ACCESS AND HARD SERVICES BUSINESS
1st Oct 20189:27 amRNSHolding(s) in Company
14th Sep 20189:58 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.